Canaccord raised the firm’s price target on Aspen Aerogels to $18 from $17 and keeps a Buy rating on the shares. The firm’s target increase reflects Aspen’s reasonable 2024 outlook, consistent operational improvement, and robust pipeline.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ASPN:
- Aspen Aerogels Projects Optimistic Financial Outlook for 2024
- Aspen Aerogels sees FY24 EPS under (30c), consensus (24c)
- Aspen Aerogels, Inc. Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Recent Business Highlights
- Aspen Aerogels reports Q4 EPS (1c), consensus (12c)
- Is ASPN a Buy, Before Earnings?
